Consistent with this mechanism, 1245A→C polymorphism was associated with a shorter time to prostate-specific antigen (PSA) recurrence, metastatic progression, and reduced overall survival of PC patients treated with ADT [4,5,10,11]. Here, KLK3 is linked to pachyonychia congenita.